SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-032584
Filing Date
2016-12-08
Accepted
2016-12-08 16:22:12
Documents
2
Period of Report
2016-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1664
2 POWER OF ATTORNEY ex-24loewy.txt EX-24 3496
  Complete submission text file 0001179110-16-032584.txt   6705
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 ELLIOTT AVE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
Loewy Caroline M (Reporting) CIK: 0001367451 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 162041689